current and emerging treatments for mf: an update from ash 2023
Published 7 months ago • 108 plays • Length 2:55Download video MP4
Download video MP3
Similar videos
-
2:00
the incorporation of immunotherapy into frontline all treatment
-
2:43
novel therapies in the future of mds treatment
-
8:40
lenalidomide, mutations & mds outcomes
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
1:31
frontline treatment for cll: the changing paradigm
-
1:54
therapeutic approaches in the front-line for patients with ptcl
-
0:52
is there a role for combination therapy in cml?
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
1:07
key advancements in the treatment of bpdcn from ebmt 2024
-
1:19
safety and efficacy of mb-106 for the treatment of r/r fl
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:04
the future of mds management
-
1:26
emerging management options for aml
-
2:41
an overview of the latest advances in hematology
-
1:13
horizon scan of mds treatments
-
4:31
labmt: impact of treatment prior to allogenic hct in mds